| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.977 | 16.551 | 15.350 | 10.617 | 25.542 | 31.548 | 17.814 | 31.415 | 37.044 | 30.150 |
| Total Income - EUR | 12.011 | 16.565 | 15.432 | 10.700 | 25.565 | 31.614 | 23.303 | 31.422 | 37.044 | 30.159 |
| Total Expenses - EUR | 3.913 | 2.299 | 7.395 | 9.373 | 8.314 | 15.902 | 15.884 | 23.587 | 34.271 | 29.999 |
| Gross Profit/Loss - EUR | 8.098 | 14.266 | 8.037 | 1.328 | 17.251 | 15.712 | 7.420 | 7.836 | 2.773 | 160 |
| Net Profit/Loss - EUR | 7.738 | 13.770 | 7.576 | 1.009 | 16.484 | 14.836 | 6.857 | 6.940 | 1.586 | -732 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioservice S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22 | 0 | 0 | 0 | 5.381 | 13.567 | 11.666 | 20.040 | 19.917 | 25.866 |
| Current Assets | 5.684 | 15.349 | 22.754 | 18.562 | 29.970 | 36.068 | 43.151 | 42.014 | 36.575 | 30.892 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117 | 0 |
| Receivables | 1.049 | 1.130 | 2.596 | 190 | 1.551 | 2.462 | 4.333 | 4.597 | 8.436 | 10.049 |
| Cash | 4.635 | 14.220 | 20.158 | 18.372 | 28.419 | 33.606 | 38.818 | 37.416 | 28.022 | 20.843 |
| Shareholders Funds | 5.316 | 15.163 | 22.438 | 18.523 | 34.649 | 48.828 | 54.602 | 50.154 | 51.587 | 50.567 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 391 | 187 | 315 | 214 | 704 | 809 | 214 | 11.900 | 4.905 | 6.191 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Bioservice S.r.l.